20 Gy Versus 30 Gy: Will it Make a Difference?

In the current issue of the Journal, Kelsey et  al., report on a phase 2 trial evaluating the use of a lower than conventional dose (20 Gy) as consolidation therapy for patients with bulky or nonbulky stage I to IV diffuse large B-cell lymphoma (DLBCL) or mediastinal large B-cell lymphoma (MLBCL) who have achieved a complete response to 4 or mo re cycles of conventional chemoimmunotherapy.1 The conventional dose in this setting has been 30 to 36 Gy.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Clinical Investigation Source Type: research